Synopsis
Synopsis
0
USDMF
0
JDMF
0
KDMF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Interceptor
2. Milbe Mite
3. Milbemycin A, 5-oxime
4. Milbemycin Oxime
1. Milbemycin A, 5-oxime
2. Unii-0502pun0gt
3. Cga-179246
4. Schembl120526
5. 0502pun0gt
6. Hy-b0778
Molecular Weight | 1097.4 g/mol |
---|---|
Molecular Formula | C63H88N2O14 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 16 |
Rotatable Bond Count | 1 |
Exact Mass | 1096.62355549 g/mol |
Monoisotopic Mass | 1096.62355549 g/mol |
Topological Polar Surface Area | 214 Ų |
Heavy Atom Count | 79 |
Formal Charge | 0 |
Complexity | 2260 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 18 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 8 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anthelmintics
Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. (See all compounds classified as Anthelmintics.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
31
PharmaCompass offers a list of Milbemycin Oxime API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Milbemycin Oxime manufacturer or Milbemycin Oxime supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Milbemycin Oxime manufacturer or Milbemycin Oxime supplier.
PharmaCompass also assists you with knowing the Milbemycin Oxime API Price utilized in the formulation of products. Milbemycin Oxime API Price is not always fixed or binding as the Milbemycin Oxime Price is obtained through a variety of data sources. The Milbemycin Oxime Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Milbemite manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Milbemite, including repackagers and relabelers. The FDA regulates Milbemite manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Milbemite API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Milbemite manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Milbemite supplier is an individual or a company that provides Milbemite active pharmaceutical ingredient (API) or Milbemite finished formulations upon request. The Milbemite suppliers may include Milbemite API manufacturers, exporters, distributors and traders.
click here to find a list of Milbemite suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Milbemite CEP of the European Pharmacopoeia monograph is often referred to as a Milbemite Certificate of Suitability (COS). The purpose of a Milbemite CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Milbemite EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Milbemite to their clients by showing that a Milbemite CEP has been issued for it. The manufacturer submits a Milbemite CEP (COS) as part of the market authorization procedure, and it takes on the role of a Milbemite CEP holder for the record. Additionally, the data presented in the Milbemite CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Milbemite DMF.
A Milbemite CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Milbemite CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Milbemite suppliers with CEP (COS) on PharmaCompass.
A Milbemite written confirmation (Milbemite WC) is an official document issued by a regulatory agency to a Milbemite manufacturer, verifying that the manufacturing facility of a Milbemite active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Milbemite APIs or Milbemite finished pharmaceutical products to another nation, regulatory agencies frequently require a Milbemite WC (written confirmation) as part of the regulatory process.
click here to find a list of Milbemite suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Milbemite as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Milbemite API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Milbemite as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Milbemite and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Milbemite NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Milbemite suppliers with NDC on PharmaCompass.
Milbemite Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Milbemite GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Milbemite GMP manufacturer or Milbemite GMP API supplier for your needs.
A Milbemite CoA (Certificate of Analysis) is a formal document that attests to Milbemite's compliance with Milbemite specifications and serves as a tool for batch-level quality control.
Milbemite CoA mostly includes findings from lab analyses of a specific batch. For each Milbemite CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Milbemite may be tested according to a variety of international standards, such as European Pharmacopoeia (Milbemite EP), Milbemite JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Milbemite USP).